Form 4: Mangoceuticals Director Acquires 100,000 Shares of Common Stock

Alex P. Hamilton, a director of Mangoceuticals, Inc., acquired 100,000 shares of common stock on June 3, 2024, as compensation for services rendered.

Summary

• On June 3, 2024, Alex P. Hamilton, a director of Mangoceuticals, Inc. (MGRX), acquired 100,000 shares of common stock.
• The acquisition was made in consideration for services rendered as a member of the Board of Directors.
• The shares were issued under the registrant's Amended and Restated 2022 Equity Incentive Plan and are exempt pursuant to Rule 16b-3.
• Following the transaction, Hamilton directly owns 175,000 shares of Mangoceuticals, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares can be seen as a good sign, but the impact is likely minimal.

Positives

• A director's increased stake in the company could signal confidence in its future prospects.

Industry Context

Director stock acquisitions are common and can be seen as a positive sign, indicating confidence in the company's future. However, the impact on the stock price is usually minimal unless the acquisition is substantial or part of a larger trend.

Stakeholder Impact

• The acquisition could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Mangoceuticals, MGRX, Director, Stock Acquisition, Form 4, Equity Incentive Plan, Alex P. Hamilton, Beneficial Ownership